Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peroxisomal biogenesis factor 11 alpha (PEX11A) is a peroxisomal membrane protein that is part of the PEX11 family, which is crucial for the proliferation and maintenance of peroxisomes, the cellular organelles responsible for various metabolic functions including fatty acid β-oxidation and lipid biosynthesis[2][4][6]. PEX11A promotes peroxisomal division primarily by remodeling and elongating the peroxisomal membrane and is involved in protein-protein interactions at the peroxisome, such as binding to other peroxisomal proteins[1][2][3][5]. Dysfunction or deficiency of PEX11A impairs peroxisome number and function, contributing to peroxisomal biogenesis disorders[2][6]. There are no known drugs directly targeting PEX11A, and it is not considered a classic therapeutic target like receptors or enzymes[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peroxisomal biogenesis factor 11 alpha (PEX11A).